Implicaciones pronósticos de biomarcadores cardiacos y escalas de comorbilidad en pacientes con infección por COVID-19 atendidos en un servicio de urgencias

Identificador:  TDX:4060

Handle: https://hdl.handle.net/20.500.11797/TDX4060

Autores:  Carrasquer Cucarella, Anna

Resumen:
1- In patients treated in the Emergency Room with discarded or confirmed COVID infection, the detection of myocardial damage is frequent and in both scenarios, it is a predictor of mortality at 30 days to a similar degree. 2- Patients with COVID-19 infection present elevated cardiac biomarkers, of which, the elevation of Troponin compared to D-dimer, PCR and LDH, shows better performance to predict mortality from COVID-19 3- The indirect analysis of viral load using ct in patients admitted with confirmed COVID-19 infection does not allow detecting patients at higher risk of presenting an unfavorable evolution compared to other serum biomarkers with prognostic impact on mortality from COVID-19 4- In patients with COVID-19 infection, elevation of troponin as a marker of myocardial damage and elevated Charlson comorbidity index identify a subgroup of patients at very high risk of short-term mortality